Davos Alzheimer’s collaborative to showcase groundbreaking progress in healthcare system innovation and inclusive global research at AAIC 2025
Business Announcement
In honor of Alzheimer's Awareness Month, we’re exploring the science and stories surrounding Alzheimer’s disease.
Updates every hour. Last Updated: 16-Dec-2025 18:11 ET (16-Dec-2025 23:11 GMT/UTC)
The Davos Alzheimer’s Collaborative (DAC),presents significant new research and implementation outcomes at the 2025 Alzheimer’s Association International Conference (AAIC) in Toronto, Canada. These include data from multi-site healthcare system implementation projects and the expansion of DAC’s research footprint across five continents.
Mathematics may not be the first thing people associate with Alzheimer’s disease research. But for Pedro Maia, an assistant professor of mathematics and data science at The University of Texas at Arlington, analyzing how different parts of the brain interact like a network is revealing new insights into one of the world’s most devastating brain disorders.
TripletDGC, an open-source GitHub toolkit, leverages single-cell RNA-seq to map nearly 10,000 disease-associated genes to their most impacted cell types—creating over 54,000 gene-disease-cell links to accelerate precision medicine and targeted drug discovery.
Dr. Hamilton Se-Hwee Oh at Mount Sinai in New York pioneers research linking differential organ aging to depression and Alzheimer's disease. His Stanford PhD work yielded breakthrough Nature publications showing organs age at different rates. Now investigating how psychological stress accelerates aging and how peripheral signals rewire brain circuits affecting mood and cognition.
Matthew Leming, PhD, and Hyungsoon Im, PhD of the Center for Systems Biology at Massachusetts General Hospital, are the co-corresponding authors of a paper published in Alzheimer’s & Dementia, “Differential dementia detection from multimodal brain images in a real-world dataset.”